
Sign up to save your podcasts
Or
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
291 Listeners
322 Listeners
49 Listeners
875 Listeners
505 Listeners
13 Listeners
87 Listeners
24 Listeners
517 Listeners
131 Listeners
362 Listeners
182 Listeners
367 Listeners
5 Listeners
79 Listeners